{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T04:10:09Z","timestamp":1771647009581,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2015R1D1A1A02061904"],"award-info":[{"award-number":["2015R1D1A1A02061904"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry for Health and Welfare, Republic of Korea","award":["1520250"],"award-info":[{"award-number":["1520250"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12885-017-3380-8","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T09:27:32Z","timestamp":1496222852000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["An objective nodal staging system for breast cancer patients undergoing neoadjuvant systemic treatment"],"prefix":"10.1186","volume":"17","author":[{"given":"Tae-Kyung","family":"Yoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Min","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee-Chul","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wonshik","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Young","family":"Noh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9981-0286","authenticated-orcid":false,"given":"Hyeong-Gon","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,31]]},"reference":[{"key":"3380_CR1","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1245\/s10434-015-4714-x","volume":"22","author":"PJ Graham","year":"2015","unstructured":"Graham PJ, Brar MS, Foster T, McCall M, Bouchard-Fortier A, Temple W, et al. Neoadjuvant chemotherapy for breast cancer, is practice changing? A population-based review of current surgical trends. Ann Surg Oncol. 2015;22:3376\u201382.","journal-title":"Ann Surg Oncol"},{"key":"3380_CR2","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jnci\/dji021","volume":"97","author":"D Mauri","year":"2005","unstructured":"Mauri D, Pavlidis N, Ioannidis JP. Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst. 2005;97:188\u201394.","journal-title":"J Natl Cancer Inst"},{"key":"3380_CR3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/bjs.5894","volume":"94","author":"JS Mieog","year":"2007","unstructured":"Mieog JS, van der Hage JA, van de Velde CJ. Neoadjuvant chemotherapy for operable breast cancer. Br J Surg. 2007;94:1189\u2013200.","journal-title":"Br J Surg"},{"key":"3380_CR4","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1093\/annonc\/mdm201","volume":"18","author":"M Kaufmann","year":"2007","unstructured":"Kaufmann M, von Minckwitz G, Bear HD, Buzdar A, McGale P, Bonnefoi H, et al. Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Ann Oncol. 2007;18:1927\u201334.","journal-title":"Ann Oncol"},{"key":"3380_CR5","doi-asserted-by":"crossref","unstructured":"King TA, Morrow M. Surgical issues in patients with breast cancer receiving neoadjuvant chemotherapy. Nat Rev Clin Oncol. 2015;12:335\u201343.","DOI":"10.1038\/nrclinonc.2015.63"},{"key":"3380_CR6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/SLA.0b013e3182686bd9","volume":"257","author":"HG Moon","year":"2013","unstructured":"Moon HG, Han W, Ahn SK, Cho N, Moon WK, Im SA, et al. Breast cancer molecular phenotype and the use of HER2-targeted agents influence the accuracy of breast MRI after neoadjuvant chemotherapy. Ann Surg. 2013;257:133\u20137.","journal-title":"Ann Surg"},{"key":"3380_CR7","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H","volume":"63","author":"CL Carter","year":"1989","unstructured":"Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer. 1989;63:181\u20137.","journal-title":"Cancer"},{"key":"3380_CR8","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/cncr.11765","volume":"98","author":"JS Michaelson","year":"2003","unstructured":"Michaelson JS, Silverstein M, Sgroi D, Cheongsiatmoy SA, Taghian A, Powell S, et al. The effect of tumor size and lymph node status on breast carcinoma lethality. Cancer. 2003;98:2133\u201343.","journal-title":"Cancer"},{"key":"3380_CR9","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.1200\/JCO.2002.02.026","volume":"20","author":"SE Singletary","year":"2002","unstructured":"Singletary SE, Allred C, Ashley P, Bassett LW, Berry D, Bland KI, et al. Revision of the American joint committee on cancer staging system for breast cancer. J Clin Oncol. 2002;20:3628\u201336.","journal-title":"J Clin Oncol"},{"key":"3380_CR10","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1245\/s10434-011-2200-7","volume":"19","author":"SA Valente","year":"2012","unstructured":"Valente SA, Levine GM, Silverstein MJ, Rayhanabad JA, Weng-Grumley JG, Ji L, et al. Accuracy of predicting axillary lymph node positivity by physical examination, mammography, ultrasonography, and magnetic resonance imaging. Ann Surg Oncol. 2012;19:1825\u201330.","journal-title":"Ann Surg Oncol"},{"key":"3380_CR11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00268-012-1788-5","volume":"37","author":"S Majid","year":"2013","unstructured":"Majid S, Tengrup I, Manjer J. Clinical assessment of axillary lymph nodes and tumor size in breast cancer compared with histopathological examination: a population-based analysis of 2,537 women. World J Surg. 2013;37:67\u201371.","journal-title":"World J Surg"},{"key":"3380_CR12","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ejso.2006.09.032","volume":"33","author":"C Lanng","year":"2007","unstructured":"Lanng C, Hoffmann J, Galatius H, Engel U. Assessment of clinical palpation of the axilla as a criterion for performing the sentinel node procedure in breast cancer. Eur J Surg Oncol. 2007;33:281\u20134.","journal-title":"Eur J Surg Oncol"},{"key":"3380_CR13","doi-asserted-by":"crossref","unstructured":"Feng Y, Huang R, He Y, Lu A, Fan Z, Fan T, et al. Efficacy of physical examination, ultrasound, and ultrasound combined with fine-needle aspiration for axilla staging of primary breast cancer. Breast Cancer Res Treat. 2015;149:761\u20135.","DOI":"10.1007\/s10549-015-3280-z"},{"key":"3380_CR14","doi-asserted-by":"crossref","unstructured":"Moon HG, Han W, Noh DY. Underweight and breast cancer recurrence and death: a report from the Korean Breast Cancer Society. J Clin Oncol. 2009;27:5899\u2013905.","DOI":"10.1200\/JCO.2009.22.4436"},{"key":"3380_CR15","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/cncr.28859","volume":"121","author":"JG Bazan","year":"2015","unstructured":"Bazan JG, White J. Imaging of the axilla before preoperative chemotherapy: implications for postmastectomy radiation. Cancer. 2015;121:1187\u201394.","journal-title":"Cancer"},{"key":"3380_CR16","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1245\/s10434-015-4717-7","volume":"22","author":"RS Jackson","year":"2015","unstructured":"Jackson RS, Mylander C, Rosman M, Andrade R, Sawyer K, Sanders T, et al. Normal axillary ultrasound excludes heavy nodal disease burden in patients with breast cancer. Ann Surg Oncol. 2015;22:3289\u201395.","journal-title":"Ann Surg Oncol"},{"key":"3380_CR17","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1245\/s10434-014-3813-4","volume":"21","author":"AS Caudle","year":"2014","unstructured":"Caudle AS, Kuerer HM, Le-Petross HT, Yang W, Yi M, Bedrosian I, et al. Predicting the extent of nodal disease in early-stage breast cancer. Ann Surg Oncol. 2014;21:3440\u20137.","journal-title":"Ann Surg Oncol"},{"key":"3380_CR18","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.breast.2013.09.002","volume":"22","author":"RJ Schipper","year":"2013","unstructured":"Schipper RJ, van Roozendaal LM, de Vries B, Pijnappel RM, Beets-Tan RG, Lobbes MG, et al. Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value? Breast. 2013;22:1108\u201313.","journal-title":"Breast"},{"key":"3380_CR19","doi-asserted-by":"crossref","unstructured":"Koolen BB, Valdes Olmos RA, Elkhuizen PH, Vogel WV, Vrancken Peeters MJ, Rodenhuis S, et al. Locoregional lymph node involvement on 18F-FDG PET\/CT in breast cancer patients scheduled for neoadjuvant chemotherapy. Breast Cancer Res Treat. 2012;135:231\u201340.","DOI":"10.1007\/s10549-012-2179-1"},{"key":"3380_CR20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3413\/Nukmed-0605-13-06","volume":"53","author":"YS An","year":"2014","unstructured":"An YS, Lee DH, Yoon JK, Lee SJ, Kim TH, Kang DK, et al. Diagnostic performance of 18F-FDG PET\/CT, ultrasonography and MRI. Detection of axillary lymph node metastasis in breast cancer patients. Nuklearmedizin. 2014;53:89\u201394.","journal-title":"Nuklearmedizin"},{"key":"3380_CR21","doi-asserted-by":"crossref","unstructured":"Koolen BB, Valdes Olmos RA, Vogel WV, Vrancken Peeters MJ, Rodenhuis S, Rutgers EJ, et al. Pre-chemotherapy 18F-FDG PET\/CT upstages nodal stage in stage II-III breast cancer patients treated with neoadjuvant chemotherapy. Breast Cancer Res Treat. 2013;141:249\u201354.","DOI":"10.1007\/s10549-013-2678-8"},{"key":"3380_CR22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.breast.2011.07.002","volume":"20","author":"IJ Robertson","year":"2011","unstructured":"Robertson IJ, Hand F, Kell MR. FDG-PET\/CT in the staging of local\/regional metastases in breast cancer. Breast. 2011;20:491\u20134.","journal-title":"Breast"},{"key":"3380_CR23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijrobp.2015.05.012","volume":"93","author":"SP Ng","year":"2015","unstructured":"Ng SP, David S, Alamgeer M, Ganju V. Impact of pretreatment combined (18)F-Fluorodeoxyglucose positron emission tomography\/computed tomography staging on radiation therapy treatment decisions in locally advanced breast cancer. Int J Radiat Oncol Biol Phys. 2015;93:111\u20137.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3380_CR24","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3109\/02841851.2010.501342","volume":"51","author":"JH Ahn","year":"2010","unstructured":"Ahn JH, Son EJ, Kim JA, Youk JH, Kim EK, Kwak JY, et al. The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer. Acta Radiol. 2010;51:859\u201365.","journal-title":"Acta Radiol"},{"key":"3380_CR25","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/bjs.10124","volume":"103","author":"DP McCartan","year":"2016","unstructured":"McCartan DP, Prichard RS, MacDermott RJ, Rothwell J, Geraghty J, Evoy D, et al. Role of bone scan in addition to CT in patients with breast cancer selected for systemic staging. Br J Surg. 2016;103:839\u201344.","journal-title":"Br J Surg"},{"key":"3380_CR26","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/00000658-198312000-00002","volume":"198","author":"U Veronesi","year":"1983","unstructured":"Veronesi U, Cascinelli N, Bufalino R, Morabito A, Greco M, Galluzzo D, et al. Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg. 1983;198:681\u20134.","journal-title":"Ann Surg"},{"key":"3380_CR27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/BF02303699","volume":"2","author":"HS Cody 3rd","year":"1995","unstructured":"Cody HS 3rd, Urban JA. Internal mammary node status: a major prognosticator in axillary node-negative breast cancer. Ann Surg Oncol. 1995;2:32\u20137.","journal-title":"Ann Surg Oncol"},{"key":"3380_CR28","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0009-9260(66)80066-1","volume":"17","author":"SM Jackson","year":"1966","unstructured":"Jackson SM. Carcinoma of the breast--the significance of supraclavicular lymph node metastases. Clin Radiol. 1966;17:107\u201314.","journal-title":"Clin Radiol"},{"key":"3380_CR29","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.clbc.2013.09.008","volume":"14","author":"S Dellapasqua","year":"2014","unstructured":"Dellapasqua S, Bagnardi V, Balduzzi A, Iorfida M, Rotmensz N, Santillo B, et al. Outcomes of patients with breast cancer who present with ipsilateral supraclavicular or internal mammary lymph node metastases. Clin Breast Cancer. 2014;14:53\u201360.","journal-title":"Clin Breast Cancer"},{"key":"3380_CR30","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1200\/JCO.2003.11.105","volume":"21","author":"IA Olivotto","year":"2003","unstructured":"Olivotto IA, Chua B, Allan SJ, Speers CH, Chia S, Ragaz J. Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer. J Clin Oncol. 2003;21:851\u20134.","journal-title":"J Clin Oncol"},{"key":"3380_CR31","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1245\/s10434-006-9012-1","volume":"13","author":"SC Chen","year":"2006","unstructured":"Chen SC, Chang HK, Lin YC, Leung WM, Tsai CS, Cheung YC, et al. Prognosis of breast cancer after supraclavicular lymph node metastasis: not a distant metastasis. Ann Surg Oncol. 2006;13:1457\u201365.","journal-title":"Ann Surg Oncol"},{"key":"3380_CR32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jamasurg.2013.3181","volume":"149","author":"SP Bagaria","year":"2014","unstructured":"Bagaria SP, Ray PS, Sim MS, Ye X, Sahmonki JM, Cui X, et al. Personalizing breast cancer staging by the inclusion of ER, PR, and HER2. JAMA Surg. 2014;149:125\u20139.","journal-title":"JAMA Surg"},{"key":"3380_CR33","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/cncr.27795","volume":"119","author":"ES Hwang","year":"2013","unstructured":"Hwang ES, Lichtensztajn DY, Gomez SL, Fowble B, Clarke CA. Survival after lumpectomy and mastectomy for early stage invasive breast cancer: the effect of age and hormone receptor status. Cancer. 2013;119:1402\u201311.","journal-title":"Cancer"},{"key":"3380_CR34","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/annonc\/mdq617","volume":"22","author":"YH Park","year":"2011","unstructured":"Park YH, Lee SJ, Cho EY, Choi YL, Lee JE, Nam SJ, et al. Clinical relevance of TNM staging system according to breast cancer subtypes. Ann Oncol. 2011;22:1554\u201360.","journal-title":"Ann Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-017-3380-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T05:00:37Z","timestamp":1569387637000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-017-3380-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,31]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["3380"],"URL":"https:\/\/doi.org\/10.1186\/s12885-017-3380-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,31]]},"article-number":"389"}}